KURA
HealthcareKura Oncology, Inc.
$8.39-0.17 (-2.04%)
Prev Close
$8.58
Open
$8.52
High
$8.57
Low
$8.27
Volume
484.3K
Market Cap
$818.0M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Kura Oncology, Inc. (KURA) has been dominated by selling, with 2 insider purchases totaling $713.3K and 22 insider sales totaling $2.31M. The most recent insider transaction was by Bair Teresa Brophy (officer: Chief Legal Officer), who sold $189.7K worth of shares on Jan 27, 2026. Kura Oncology, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $818.0M.
Buys (12M)
2
$713.3K
Sells (12M)
22
$2.31M
Net Activity
Net Seller
$1.60M
Active Insiders
9
last 12 mo
KURA Price Chart
KURA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026↗ | Bair Teresa Brophy | officer: Chief Legal Officer | Sell | 22,416 | $8.46 | $189.7K | 234,043 |
| Jan 27, 2026↗ | Burrows Francis | officer: Chief Scientific Officer | Sell | 2,622 | $8.46 | $22.2K | 32,424 |
| Jan 27, 2026↗ | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 9,832 | $8.46 | $83.2K | 150,083 |
| Jan 27, 2026↗ | FORD KATHLEEN | officer: Chief Operating Officer | Sell | 3,626 | $8.46 | $30.7K | 153,560 |
| Jan 27, 2026↗ | Leoni Mollie | officer: Chief Medical Officer | Sell | 16,360 | $8.46 | $138.4K | 271,799 |
| Jan 27, 2026↗ | Powl Brian T. | officer: Chief Commercial Officer | Sell | 12,828 | $8.46 | $108.5K | 184,847 |
| Dec 18, 2025↗ | Burrows Francis | Chief Scientific Officer | Sell | 23,726 | $9.78 | $231.9K | 0 |
| Dec 9, 2025↗ | Hasnain Faheem | Director | Sell | 10,000 | $10.98 | $109.8K | 0 |
| Nov 13, 2025↗ | Bair Teresa Brophy | Chief Legal Officer | Sell | 8,804 | $11.18 | $98.4K | 0 |
| Nov 13, 2025↗ | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 4,539 | $11.18 | $50.7K | 0 |
| Nov 13, 2025↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 6,902 | $11.18 | $77.1K | 0 |
| Nov 13, 2025↗ | Leoni Mollie | Chief Medical Officer | Sell | 15,485 | $11.18 | $173.1K | 0 |
| Nov 13, 2025↗ | Powl Brian T. | Chief Commercial Officer | Sell | 8,887 | $11.18 | $99.3K | 0 |
| Sep 27, 2025↗ | Bair Teresa Brophy | Chief Legal Officer | Sell | 8,805 | $8.94 | $78.7K | 0 |
| Sep 27, 2025↗ | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 4,541 | $8.94 | $40.6K | 0 |
| Sep 27, 2025↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 6,892 | $8.94 | $61.6K | 0 |
| Sep 27, 2025↗ | Leoni Mollie | Chief Medical Officer | Sell | 12,314 | $8.94 | $110.1K | 0 |
| Sep 27, 2025↗ | Powl Brian T. | Chief Commercial Officer | Sell | 8,891 | $8.94 | $79.5K | 0 |
| Sep 27, 2025↗ | WILSON TROY EDWARD | President and CEO | Sell | 36,615 | $8.94 | $327.4K | 0 |
| Sep 8, 2025↗ | WILSON TROY EDWARD | President & CEO | Buy | 50,000 | $8.20 | $410.1K | 0 |
| Aug 12, 2025↗ | WILSON TROY EDWARD | President and CEO | Buy | 50,000 | $6.06 | $303.2K | 0 |
| May 19, 2025↗ | Bair Teresa Brophy | Chief Legal Officer | Sell | 1,559 | $5.96 | $9.3K | 0 |
| May 19, 2025↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 1,558 | $6.28 | $9.8K | 0 |
| Mar 21, 2025↗ | Hasnain Faheem | Director | Sell | 22,682 | $8.00 | $181.5K | 0 |
| Jan 28, 2025↗ | Bair Teresa Brophy | Chief Legal Officer | Sell | 7,281 | $7.87 | $57.3K | 112,792 |
| Jan 28, 2025↗ | Burrows Francis | Chief Scientific Officer | Sell | 2,166 | $7.87 | $17.1K | 22,025 |
| Jan 28, 2025↗ | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 4,949 | $7.87 | $39.0K | 90,901 |
| Jan 28, 2025↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 1,817 | $7.87 | $14.3K | 21,367 |
| Jan 28, 2025↗ | Leoni Mollie | Chief Medical Officer | Sell | 4,963 | $7.87 | $39.1K | 90,963 |
| Jan 28, 2025↗ | Powl Brian T. | Chief Commercial Officer | Sell | 1,583 | $7.87 | $12.5K | 59,667 |
| Nov 19, 2024↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 526 | $16.03 | $8.4K | 23,184 |
| May 20, 2024↗ | Bair Teresa Brophy | Chief Legal Officer | Sell | 2,615 | $22.15 | $57.9K | 68,979 |
| Jan 31, 2024↗ | Bair Teresa Brophy | Chief Legal Officer | Sell | 2,053 | $17.80 | $36.5K | 68,979 |
| Jan 31, 2024↗ | DALE STEPHEN | Chief Medical Officer | Sell | 11,983 | $19.31 | $231.4K | 46,400 |
| Jan 31, 2024↗ | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 2,318 | $17.80 | $41.3K | 49,817 |
| Jan 31, 2024↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 1,496 | $17.80 | $26.6K | 21,602 |
| Jan 26, 2024↗ | WILSON TROY EDWARD | President and CEO | Sell | 91,052 | $20.23 | $1.84M | 559 |
| Jun 21, 2023↗ | Malley Thomas | Director | Buy | 50,000 | $11.50 | $575.0K | 139,557 |
| Jan 31, 2023↗ | DALE STEPHEN | Chief Medical Officer | Sell | 9,225 | $13.88 | $128.0K | 32,515 |
| Jan 31, 2023↗ | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 1,548 | $13.89 | $21.5K | 17,707 |
| Jan 31, 2023↗ | FLOWERS KIRSTEN | CCO & Chief Strategy Officer | Sell | 1,906 | $13.89 | $26.5K | 20,605 |
| Jan 31, 2023↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 1,821 | $13.89 | $25.3K | 21,214 |
| Nov 18, 2022↗ | Bair Teresa Brophy | Chief Legal Officer | Sell | 2,100 | $15.22 | $32.0K | 0 |
| Mar 17, 2021↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 6,250 | $29.43 | $184.0K | 0 |
KURA Insider Buying Activity
The following table shows recent insider purchases of Kura Oncology, Inc. (KURA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 8, 2025↗ | WILSON TROY EDWARD | President & CEO | Buy | 50,000 | $8.20 | $410.1K | 0 |
| Aug 12, 2025↗ | WILSON TROY EDWARD | President and CEO | Buy | 50,000 | $6.06 | $303.2K | 0 |
| Jun 21, 2023↗ | Malley Thomas | Director | Buy | 50,000 | $11.50 | $575.0K | 139,557 |
KURA Insider Selling Activity
The following table shows recent insider sales of Kura Oncology, Inc. (KURA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026↗ | Bair Teresa Brophy | officer: Chief Legal Officer | Sell | 22,416 | $8.46 | $189.7K | 234,043 |
| Jan 27, 2026↗ | Burrows Francis | officer: Chief Scientific Officer | Sell | 2,622 | $8.46 | $22.2K | 32,424 |
| Jan 27, 2026↗ | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 9,832 | $8.46 | $83.2K | 150,083 |
| Jan 27, 2026↗ | FORD KATHLEEN | officer: Chief Operating Officer | Sell | 3,626 | $8.46 | $30.7K | 153,560 |
| Jan 27, 2026↗ | Leoni Mollie | officer: Chief Medical Officer | Sell | 16,360 | $8.46 | $138.4K | 271,799 |
| Jan 27, 2026↗ | Powl Brian T. | officer: Chief Commercial Officer | Sell | 12,828 | $8.46 | $108.5K | 184,847 |
| Dec 18, 2025↗ | Burrows Francis | Chief Scientific Officer | Sell | 23,726 | $9.78 | $231.9K | 0 |
| Dec 9, 2025↗ | Hasnain Faheem | Director | Sell | 10,000 | $10.98 | $109.8K | 0 |
| Nov 13, 2025↗ | Bair Teresa Brophy | Chief Legal Officer | Sell | 8,804 | $11.18 | $98.4K | 0 |
| Nov 13, 2025↗ | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 4,539 | $11.18 | $50.7K | 0 |
| Nov 13, 2025↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 6,902 | $11.18 | $77.1K | 0 |
| Nov 13, 2025↗ | Leoni Mollie | Chief Medical Officer | Sell | 15,485 | $11.18 | $173.1K | 0 |
| Nov 13, 2025↗ | Powl Brian T. | Chief Commercial Officer | Sell | 8,887 | $11.18 | $99.3K | 0 |
| Sep 27, 2025↗ | Bair Teresa Brophy | Chief Legal Officer | Sell | 8,805 | $8.94 | $78.7K | 0 |
| Sep 27, 2025↗ | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 4,541 | $8.94 | $40.6K | 0 |
| Sep 27, 2025↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 6,892 | $8.94 | $61.6K | 0 |
| Sep 27, 2025↗ | Leoni Mollie | Chief Medical Officer | Sell | 12,314 | $8.94 | $110.1K | 0 |
| Sep 27, 2025↗ | Powl Brian T. | Chief Commercial Officer | Sell | 8,891 | $8.94 | $79.5K | 0 |
| Sep 27, 2025↗ | WILSON TROY EDWARD | President and CEO | Sell | 36,615 | $8.94 | $327.4K | 0 |
| May 19, 2025↗ | Bair Teresa Brophy | Chief Legal Officer | Sell | 1,559 | $5.96 | $9.3K | 0 |
| May 19, 2025↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 1,558 | $6.28 | $9.8K | 0 |
| Mar 21, 2025↗ | Hasnain Faheem | Director | Sell | 22,682 | $8.00 | $181.5K | 0 |
| Jan 28, 2025↗ | Bair Teresa Brophy | Chief Legal Officer | Sell | 7,281 | $7.87 | $57.3K | 112,792 |
| Jan 28, 2025↗ | Burrows Francis | Chief Scientific Officer | Sell | 2,166 | $7.87 | $17.1K | 22,025 |
| Jan 28, 2025↗ | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 4,949 | $7.87 | $39.0K | 90,901 |
| Jan 28, 2025↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 1,817 | $7.87 | $14.3K | 21,367 |
| Jan 28, 2025↗ | Leoni Mollie | Chief Medical Officer | Sell | 4,963 | $7.87 | $39.1K | 90,963 |
| Jan 28, 2025↗ | Powl Brian T. | Chief Commercial Officer | Sell | 1,583 | $7.87 | $12.5K | 59,667 |
| Nov 19, 2024↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 526 | $16.03 | $8.4K | 23,184 |
| May 20, 2024↗ | Bair Teresa Brophy | Chief Legal Officer | Sell | 2,615 | $22.15 | $57.9K | 68,979 |
| Jan 31, 2024↗ | Bair Teresa Brophy | Chief Legal Officer | Sell | 2,053 | $17.80 | $36.5K | 68,979 |
| Jan 31, 2024↗ | DALE STEPHEN | Chief Medical Officer | Sell | 11,983 | $19.31 | $231.4K | 46,400 |
| Jan 31, 2024↗ | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 2,318 | $17.80 | $41.3K | 49,817 |
| Jan 31, 2024↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 1,496 | $17.80 | $26.6K | 21,602 |
| Jan 26, 2024↗ | WILSON TROY EDWARD | President and CEO | Sell | 91,052 | $20.23 | $1.84M | 559 |
| Jan 31, 2023↗ | DALE STEPHEN | Chief Medical Officer | Sell | 9,225 | $13.88 | $128.0K | 32,515 |
| Jan 31, 2023↗ | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | 1,548 | $13.89 | $21.5K | 17,707 |
| Jan 31, 2023↗ | FLOWERS KIRSTEN | CCO & Chief Strategy Officer | Sell | 1,906 | $13.89 | $26.5K | 20,605 |
| Jan 31, 2023↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 1,821 | $13.89 | $25.3K | 21,214 |
| Nov 18, 2022↗ | Bair Teresa Brophy | Chief Legal Officer | Sell | 2,100 | $15.22 | $32.0K | 0 |
| Mar 17, 2021↗ | FORD KATHLEEN | Chief Operating Officer | Sell | 6,250 | $29.43 | $184.0K | 0 |
KURA Insiders
Similar Stocks to KURA
VRTX
Vertex Pharmaceuticals Incorporated
$452.29-2.20%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$745.34-1.66%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$317.24-0.96%
$42.07B
INSM
Insmed Incorporated
$143.85-0.06%
$30.07B
UTHR
United Therapeutics Corporation
$531.23-1.63%
$23.50B
MRNA
Moderna, Inc.
$52.27-3.15%
$20.76B
ROIV
Roivant Sciences Ltd.
$27.86-1.55%
$20.08B
RPRX
Royalty Pharma plc
$45.94-0.36%
$19.56B